canin
influenza
viru
civ
subtyp
newli
identifi
highli
contagi
respiratori
pathogen
caus
cough
pneumonia
respiratori
symptom
dog
data
indic
viru
respons
recent
clinic
case
dog
diseas
china
howev
therapeut
option
diseas
limit
studi
seven
monoclon
antibodi
mab
civ
subtyp
viru
produc
character
among
mab
specif
glycopeptid
gp
induc
highest
neutral
titer
protect
provid
mab
evalu
balbc
mice
challeng
homolog
heterolog
strain
influenza
viru
includ
two
strain
civ
one
strain
swine
influenza
viru
siv
data
show
mab
protect
mice
infect
three
viral
strain
especi
homolog
strain
indic
recoveri
bodi
weight
reduct
viral
load
reduct
tissu
damag
moreov
level
lung
detect
elisa
reduc
infect
mice
treat
mab
compar
without
mab
treatment
thu
find
demonstr
first
time
mab
could
reduc
releas
associ
tissu
damag
civ
infect
mab
might
great
therapeut
valu
civ
infect
influenza
viru
highli
contagi
pathogen
infect
bird
mammal
undergon
signific
genet
variat
adapt
differ
host
interspecif
transmiss
achiev
recombin
direct
transfer
genet
materi
first
case
dog
infect
canin
influenza
viru
civ
report
usa
follow
report
civ
south
korea
subsequ
demonstr
civ
abl
transmit
directli
dog
dog
recent
first
case
civ
infect
report
guangdong
provinc
recent
year
infect
civ
dog
develop
scatter
case
wide
distribut
across
countri
dog
natur
immun
viru
thu
number
prevent
therapeut
measur
civ
attempt
control
preval
viru
among
vaccin
import
method
prevent
control
influenza
viru
infect
current
vaccin
research
civ
made
progress
us
depart
agricultur
usda
approv
list
vaccin
civ
could
effect
reduc
viral
shed
patent
civ
vaccin
south
korea
also
approv
prevent
vaccin
histor
primari
measur
control
influenza
viru
infect
limit
exampl
influenza
vaccin
may
effect
enough
prevent
diverg
viral
strain
may
less
immunogen
effect
certain
group
young
old
immunocompromis
therefor
crucial
develop
measur
protect
anim
infectiondiseas
exampl
passiv
immun
transfer
specif
antibodi
recipi
could
protect
anim
infect
monoclon
antibodi
mab
neutral
virus
thu
prevent
viru
attach
fusion
host
cell
mani
studi
demonstr
mab
effect
prevent
treatment
humanorigin
avianorigin
influenza
viru
infect
howev
date
neutral
mab
avail
prevent
control
civ
infect
studi
identifi
seven
mab
civ
test
one
mab
three
differ
subtyp
viru
strain
anim
experi
first
descript
neutral
mab
civ
three
viral
strain
subtyp
includ
acanineguangdong
use
studi
genbank
access
number
respect
three
viral
strain
adapt
mice
passag
time
propag
specificpathogen
free
spf
embryon
chicken
egg
store
use
madindarbi
canin
kidney
mdck
cell
cultur
dulbecco
modifi
essenti
medium
dmem
contain
vv
fetal
bovin
serum
hyclon
tah
usa
maintain
vv
co
atmospher
balbc
mice
week
old
femal
purchas
anim
experi
center
yangzhou
univers
anim
experi
compli
guidelin
anim
welfar
council
china
anim
ethic
committe
nanj
agricultur
univers
approv
studi
fiftyperc
tissu
cultur
infect
dose
tcid
assay
one
day
infect
dish
contain
monolay
mdck
cell
prepar
next
day
serial
dilut
three
influenza
viru
strain
made
cell
monolay
later
inocul
dilut
three
replic
cytopath
effect
cpe
observ
daili
number
well
viru
dilut
show
less
patholog
chang
record
tcid
titer
calcul
accord
reedmuench
method
canin
influenza
viru
grown
spf
embryon
chicken
egg
h
allanto
fluid
harvest
hemagglutin
ha
activ
allanto
fluid
test
room
temperatur
use
chicken
red
blood
cell
rbc
ha
titer
equal
select
viru
purifi
use
differenti
centrifug
sucros
densiti
gradient
centrifug
prepar
mab
follow
standard
hybridoma
technolog
previous
describ
sixweekold
femal
balbc
mice
inject
intracutan
purifi
viru
use
complet
freund
adjuv
sigma
beij
china
primari
adjuv
follow
incomplet
freund
adjuv
three
day
harvest
splenocyt
inocul
intraven
isol
screen
hybridoma
perform
describ
previous
mab
prepar
inject
hybridoma
cell
periton
caviti
pristaneprim
balbc
mice
ascet
fluid
collect
day
inactiv
min
hi
test
perform
assess
antibodi
reactiv
three
strain
previous
describ
briefli
serial
twofold
dilut
purifi
dilut
ascet
fluid
mab
mix
ha
unit
viru
dispos
hemagglutin
plate
incub
min
chicken
rbc
ad
well
incub
room
temperatur
min
rule
nonspecif
inhibit
hi
assay
use
ascet
fluid
produc
inject
myeloma
cell
neg
control
hi
titer
express
reciproc
highest
serum
dilut
complet
inhibit
hemagglutin
ha
unit
viru
cellbas
neutral
assay
perform
previous
describ
dose
tcid
virus
use
assay
supernat
ascit
test
start
dilut
briefli
twofold
dilut
hybridoma
supernat
mix
viru
suspens
contain
tcid
purifi
viru
incub
co
incub
h
addit
monolay
mdck
cell
plate
one
hundr
microlit
serumfre
dmem
ad
well
incub
continu
h
cytopath
effect
observ
everi
h
h
determin
recogn
ha
domain
mab
recombinantli
express
ha
protein
viru
recombin
protein
subject
sdspage
reduc
condit
protein
electrotransf
immobil
nitrocellulos
membran
membran
block
nonfat
milk
phosphat
buffer
salin
pb
contain
tween
pbst
h
membran
subsequ
incub
mab
prepar
studi
rins
pbst
incub
horseradish
peroxidas
hrp
conjug
rabbit
antimous
immunoglobulin
biorad
shanghai
china
follow
incub
chromogen
reagent
tiangen
beij
china
crossprotect
mab
balbc
mice
use
determin
protect
efficaci
mab
intranas
inocul
tcid
viru
strain
given
experiment
group
n
ii
n
iii
n
respect
control
group
receiv
pb
n
experiment
group
divid
three
subgroup
n
subgroup
virusinfect
mab
irrelev
mab
igg
subgroup
respect
mice
inject
pb
irrelev
mab
igg
consid
blank
neg
control
respect
mab
irrelev
mab
igg
subgroup
mice
pretreat
intraperiton
mab
irrelev
mab
igg
igm
chines
bream
develop
laboratori
dose
mg
per
kg
bodi
weight
pb
viral
challeng
h
mice
challeng
three
differ
strain
mice
observ
daili
monitor
bodi
weight
clinic
symptom
day
three
mice
subgroup
euthan
human
accord
predesign
schedul
day
postinfect
dpi
blood
sampl
tissu
includ
heart
spleen
lung
brain
intestin
well
fece
collect
viru
shed
detect
screen
fecal
sampl
detect
viral
rna
use
determin
tissu
distribut
viru
shed
tissu
fece
homogen
lysat
ratio
gml
respect
centrifug
g
min
supernat
collect
extract
viral
rna
use
viru
nucleic
acid
extract
kit
ii
geneaid
taiwan
tissu
collect
includ
blood
use
viru
titrat
lung
brain
heart
also
use
histolog
immunohistochem
analysi
dpi
quantit
assay
carri
measur
viral
load
blood
main
organ
total
rna
tissu
blood
sampl
revers
transcrib
use
rt
reagent
kit
gdna
eras
perfect
real
time
takara
dalian
china
run
abi
real
time
pcr
system
use
premix
ex
taqtm
perfect
real
time
kit
takara
revers
transcript
cdna
amplif
carri
describ
previous
primer
use
design
region
matrix
gene
refer
standard
prepar
use
simpl
vector
takara
contain
correspond
target
viru
sequenc
seri
eight
dilut
equival
copi
per
reaction
prepar
gener
calibr
curv
run
parallel
test
sampl
rna
amount
two
avianorigin
civ
humanorigin
influenza
virus
calcul
standard
curv
realtim
rtpcr
detect
limit
assay
copi
rna
per
ml
euthanasia
dpi
heart
brain
lung
mice
inocul
pb
collect
place
neutral
buffer
formalin
fixat
tissu
embed
paraffin
section
stain
hematoxylin
eosin
histolog
evalu
sequenti
slide
stain
use
immunoperoxidas
method
express
hemagglutinin
tissu
examin
immunohistochem
stain
histolog
section
brief
section
block
bovin
serum
albuminpb
stain
mab
dilut
one
hour
follow
biotin
conjug
goat
antimous
immunoglobulin
biorad
dilut
min
section
subsequ
incub
hrp
conjug
streptavidin
biorad
min
section
develop
hrpdab
chromogen
substrat
kit
tiangen
min
counterstain
hematoxylin
lung
assign
grade
base
histolog
charact
lesion
score
criteria
differ
grade
accord
previou
studi
investig
correl
sever
diseas
inflammatori
cytokin
product
viruschalleng
mice
ascertain
whether
passiv
immun
antibodi
affect
level
cytokin
involv
defens
three
differ
influenza
viru
infect
section
lung
altern
right
left
lung
mice
homogen
ml
pb
per
g
lung
tissu
homogen
centrifug
supernat
frozen
test
supernat
assay
gamma
interferon
tumor
necrosi
factor
use
elisa
kit
sigmaaldrich
beij
minimum
detect
limit
assay
follow
pgml
pgml
previous
determin
manufactur
data
collect
analyz
use
ms
excel
spss
static
softwar
weight
loss
viral
titer
cytokin
level
histolog
score
analyz
analysi
varianc
anova
follow
turkey
multipl
comparison
test
p
consid
signific
differ
p
consid
statist
extrem
signific
civ
propag
mdck
cell
titer
three
viral
strain
determin
tcid
ml
tcid
ml
tcid
ml
respect
fusion
spleen
cell
virusimmun
mice
myeloma
cell
obtain
seven
mab
viru
isotyp
test
show
mab
isotyp
except
one
seven
mab
identifi
four
mab
react
ha
among
four
mab
mab
react
three
mab
react
figur
demonstr
western
blot
hi
neutral
titer
seven
mab
show
mab
highest
neutral
activ
hi
activ
tabl
analysi
indic
mab
could
react
viru
strain
produc
high
neutral
activ
three
viral
strain
especi
homolog
strain
tabl
access
protect
efficaci
mab
inocul
mice
three
differ
strain
one
day
treatment
mab
three
day
inocul
mice
challeng
three
viru
strain
exhibit
clinic
sign
infect
includ
depress
decreas
activ
huddl
similar
clinic
sign
observ
irrelev
mab
igg
pretreat
group
howev
similar
pb
control
group
mice
mab
pretreat
group
seem
energet
good
appetit
infect
term
bodi
weight
mice
challeng
treatment
show
similar
increas
bodi
weight
compar
pb
control
group
signific
differ
two
group
figur
b
c
dpi
mice
treat
mab
show
bodi
weight
increas
nearli
although
bodi
weight
virusinfect
group
irrelev
mab
igg
group
demonstr
upward
trend
growth
rate
slower
mab
group
extent
increas
bodi
weight
significantli
slower
compar
mab
group
dpi
p
figur
group
mice
infect
bodi
weight
mice
three
experiment
group
show
upward
trend
growth
rate
mice
treat
mab
much
higher
two
group
addit
bodi
weight
chang
mice
mab
group
figur
antigen
identif
mab
western
blot
use
recombin
protein
ha
lane
protein
prestain
mass
marker
lane
mab
react
express
viral
protein
ha
lane
mab
react
recombin
protein
visual
lane
mab
react
express
protein
viral
protein
identifi
dab
stain
hrplabel
goat
antimous
secondari
antibodi
dpi
significantli
differ
two
experiment
group
p
mice
mab
group
show
weight
gain
nearli
significantli
differ
pb
control
group
figur
howev
infect
mice
virusinfect
group
show
slight
result
express
term
percent
bodi
weight
p
p
indic
signific
differ
weight
data
mab
treat
group
compar
virusinfect
group
irrelev
mab
igg
group
p
indic
signific
differ
weight
data
pb
group
compar
mab
treat
group
viral
load
lung
e
f
result
express
term
mean
number
copiesg
rna
standard
deviat
p
p
indic
significantli
differ
viru
titer
mab
group
compar
two
group
indic
proport
lung
viru
could
detect
decreas
bodi
weight
dpi
mice
mab
igg
group
display
slight
declin
dpi
contrast
mice
mab
group
continu
grow
p
p
dpi
p
growth
rate
mab
group
significantli
higher
virusinfect
group
mab
igg
group
slightli
lower
pb
control
group
dpi
mice
bodi
weight
gain
mab
group
reach
approxim
figur
realtim
pcr
use
evalu
kinet
viral
rna
load
lung
heart
brain
spleen
intestin
fece
blood
infect
mice
viral
titer
express
number
copi
viral
rna
dynam
chang
viral
titer
lung
mice
virusinfect
group
mab
group
irrelev
mab
igg
group
similar
peak
viral
titer
observ
day
infect
viral
titer
declin
dpi
figur
e
f
howev
viral
titer
lung
mice
treat
mab
significantli
lower
mice
two
group
specif
time
point
challeng
viral
load
lung
mice
treat
mab
significantli
lower
two
group
dpi
p
figur
strain
viral
titer
lung
mab
group
significantli
lower
compar
two
experiment
group
p
dpi
p
addit
dpi
viral
rna
could
detect
lung
sampl
respect
mab
group
figur
viru
viral
titer
mice
mab
group
significantli
lower
two
group
p
p
dpi
p
figur
mice
virusinfect
group
peak
viral
titer
three
viru
strain
copiesg
respect
mice
mab
group
peak
valu
copiesg
respect
consid
mab
result
signific
reduct
viral
titer
lung
mice
infect
three
differ
viru
strain
dpi
chose
time
point
determin
viral
rna
load
differ
tissu
fecal
sampl
found
viral
load
collect
fece
blood
tissu
dpi
mab
group
also
lower
two
group
figur
mice
challeng
viru
viral
titer
lung
heart
intestin
fece
blood
mab
group
decreas
p
p
p
p
p
fold
respect
compar
two
group
figur
mice
challeng
viru
viral
titer
lung
heart
spleen
fece
blood
mice
treat
mab
found
reduc
p
p
p
p
p
fold
comparison
two
group
figur
viru
mab
result
reduct
viral
titer
lung
spleen
intestin
fece
blood
p
p
p
p
p
fold
respect
figur
gener
mab
could
reduc
viral
load
three
viru
strain
infect
mice
notabl
virusinfect
group
irrelev
mab
igg
group
infect
viru
even
till
dpi
viru
rna
detect
tissu
mice
treat
mab
viru
rna
could
detect
brain
almost
tissu
except
lung
blood
dpi
addit
file
viru
dpi
viral
titer
detect
tissu
much
lower
compar
two
virus
three
group
viral
titer
tissu
undetect
mice
mab
group
show
much
faster
viru
clearanc
rate
two
group
dpi
viru
detect
intestin
fece
three
mice
mab
group
dpi
viru
undetect
tissu
mice
treat
mab
except
lung
one
mous
addit
file
howev
mice
infect
viru
show
longest
retent
time
dpi
nearli
tissu
mice
virusinfect
irrelev
mab
igg
group
show
detect
viru
rna
even
mab
group
mice
show
posit
viru
rna
detect
tissu
except
intestin
fece
addit
file
compar
result
patholog
find
mice
infect
three
differ
viru
strain
treat
mab
irrelev
mab
igg
chose
heart
brain
lung
differ
treatment
group
dpi
perform
histopatholog
immunohistochem
analysi
sampl
tissu
mice
virusinfect
group
show
signific
lesion
viral
antigen
stain
control
group
show
lesion
mice
treat
mab
markedli
fewer
lesion
compar
virusinfect
group
figur
histolog
lesion
mab
igg
group
show
similar
result
virusinfect
group
data
shown
regardless
viru
strain
lung
interstiti
space
obvious
widen
bronchial
lumen
becam
narrow
alveolar
septum
thicken
infiltr
number
inflammatori
cell
figur
c
larg
area
lung
appear
consolid
symptom
pulmonari
congest
figur
interstiti
pneumonia
also
obviou
alveolar
figur
viral
load
collect
tissu
fecal
sampl
mice
dpi
mice
pretreat
mgkg
mab
mab
igg
pb
day
viral
challeng
viru
b
c
respect
viru
group
lung
heart
brain
spleen
intestin
fece
blood
mice
collect
determin
viral
load
use
realtim
pcr
day
postchalleng
p
p
indic
significantli
differ
viru
titer
compar
two
group
septum
prolifer
connect
tissu
infiltr
numer
macrophag
around
bronchioli
blood
vessel
figur
e
brief
histolog
lesion
character
multifoc
coalesc
reddish
consolid
mice
infect
viru
virusinfect
irrelev
mab
igg
group
howev
degre
histolog
lesion
observ
sever
show
least
sever
lesion
among
three
virus
mice
treat
mab
show
mild
necrot
bronchiol
ciliat
tracheal
epithelium
mild
hyperplasia
figur
addit
small
gap
observ
alveoli
excess
amount
alveolar
macrophag
lung
figur
viru
strain
mab
demonstr
best
protect
efficaci
compar
two
virus
mice
pb
group
show
bronchia
simpl
ciliat
columnar
epithelium
alveolar
caviti
vacuol
thinwal
structur
figur
viral
antigen
stain
present
almost
bronchiolar
epitheli
cell
alveolar
cell
dpi
viru
challeng
figur
c
e
mice
mab
show
littl
viru
antigen
stain
surround
vessel
near
alveoli
figur
f
pb
control
group
viral
stain
figur
lung
grade
degre
injuri
dpi
shown
figur
significantli
less
injuri
lung
mab
group
virusinfect
group
mab
igg
group
viru
strain
similar
lung
mice
virusinfect
group
show
histolog
lesion
brain
extent
histolog
lesion
infect
sever
least
sever
sever
infect
may
depend
differ
viru
titer
cerebrum
congest
hemorrhag
evid
nerv
fiber
dissolv
neuron
necrolysislik
vacuol
glial
nodul
neuronophagia
also
observ
figur
q
dilat
hyperemia
found
capillari
figur
moreov
microgli
cell
nerv
cell
show
satellit
phenomenon
cytoplasm
neuron
basophil
contract
figur
q
viral
antigen
could
detect
glial
nodul
microglialgath
area
figur
q
brain
mice
treat
mab
mild
lesion
surround
microgli
cell
nerv
cell
figur
almost
antigen
stain
found
figur
pb
control
group
show
histolog
find
figur
viral
stain
figur
heart
mice
virusinfect
group
cardiac
striat
muscl
disord
full
vacuol
character
myocard
lymphocyt
infiltr
observ
figur
lymphoprolifer
also
found
among
muscl
fiber
figur
nuclei
show
pyknosi
myocardi
cell
show
coagul
necrosi
figur
l
gain
better
understand
effect
civ
innat
immun
respons
ascertain
whether
passiv
immun
monoclon
antibodi
affect
level
cytokin
examin
level
lung
mice
virusinfect
mab
group
shown
figur
level
respons
three
viru
strain
show
ident
trend
higher
dpi
dpi
level
mab
group
three
viru
strain
significantli
lower
virusinfect
group
mab
igg
group
especi
dpi
howev
cytokin
level
differ
variou
viru
strain
viru
strain
level
group
reach
peak
dpi
exhibit
overal
downward
trend
cytokin
level
mab
group
p
dpi
p
significantli
lower
virusinfect
mab
igg
group
howev
level
show
signific
differ
among
three
group
time
point
figur
level
mab
group
return
normal
dpi
two
group
return
normal
level
dpi
viru
strain
level
three
experiment
group
significantli
higher
mice
pb
group
p
p
dpi
p
sustain
rel
high
level
dpi
decreas
peak
level
mab
igg
group
lower
compar
two
viru
strain
dpi
figur
although
level
three
experiment
group
challeng
show
much
differ
compar
level
mab
group
dpi
return
normal
level
significantli
lower
p
compar
two
group
three
group
show
normal
level
dpi
viru
strain
viru
induc
largest
rise
level
level
degre
lung
injuri
infect
viru
dpi
lung
assign
grade
base
histolog
charact
lesion
p
p
indic
significantli
differ
score
mab
group
compar
two
group
group
significantli
higher
two
virus
dpi
addit
mice
virusinfect
mab
igg
group
demonstr
trend
period
dpi
p
ie
signific
elev
follow
downward
trend
figur
although
level
mab
group
dpi
rel
high
compar
pb
group
level
significantli
lower
two
group
p
dpi
p
declin
normal
level
dpi
figur
character
secret
lung
tissu
mice
challeng
viru
cytokin
concentr
measur
elisa
supernat
homogen
lung
infect
three
viru
strain
mice
pretreat
mgkg
mab
mab
igg
pb
day
challeng
viru
b
e
c
f
respect
cytokin
level
measur
infect
mice
day
post
challeng
result
express
term
pgml
p
p
indic
significantli
differ
chang
mab
group
compar
virusinfect
group
mab
igg
group
p
p
indic
signific
differ
group
pb
control
group
chang
level
infect
three
viru
strain
level
mice
group
slightli
higher
pb
group
dpi
increas
dpi
level
reach
maximum
dpi
decreas
dpi
howev
cytokin
level
still
higher
control
group
dpi
quit
differ
compar
level
increas
level
lower
compar
level
addit
level
mab
group
appar
lower
virusinfect
group
mab
igg
group
especi
dpi
viru
strain
level
virusinfect
group
mab
igg
group
show
small
rise
dpi
reach
peak
dpi
declin
howev
cytokin
level
still
significantli
higher
p
pb
group
figur
level
mab
group
dpi
p
remark
lower
virusinfect
group
mab
igg
group
decreas
similar
level
pb
group
viru
strain
level
three
experiment
group
increas
dpi
return
normal
dpi
figur
level
mab
group
dpi
significantli
lower
p
two
group
cytokin
level
show
much
differ
three
group
time
point
viru
strain
level
virusinfect
group
mab
group
markedli
higher
pb
group
dpi
figur
although
level
mab
group
also
significantli
higher
p
pb
group
except
dpi
level
mab
group
significantli
lower
p
compar
virusinfect
irrelev
mab
igg
group
dpi
civ
newli
identifi
avian
influenza
viru
aiv
subtyp
infect
dog
transmit
directli
dog
dog
civ
infect
report
sever
countri
includ
south
korea
china
import
develop
set
measur
prevent
control
civ
infect
dog
antibodymedi
passiv
immun
provid
protect
invad
pathogen
studi
develop
seven
mab
whose
pathogen
character
mice
dog
among
four
mab
react
ha
ha
glycoprotein
primari
target
antibodi
confer
protect
immun
influenza
virus
therefor
gener
neutral
antibodi
antigen
site
ha
glycoprotein
regard
criterion
evalu
immun
influenza
virus
believ
constitut
main
correl
protect
antiha
globular
head
mab
potent
neutral
activ
homolog
strain
limit
breadth
reactiv
high
variabl
aminoacid
chang
globular
head
ha
stalk
howev
conserv
region
ha
among
influenza
viru
subtyp
respons
fusion
viru
endosom
membran
entri
viru
cell
western
blot
show
mab
recogn
domain
highest
neutral
activ
although
mab
lack
hi
activ
previou
studi
report
lack
vitro
hi
activ
mab
rule
protect
activ
vivo
therefor
select
mab
evalu
regard
protect
differ
influenza
viru
strain
investig
protect
mab
homolog
heterolog
strain
influenza
virus
select
three
viru
strain
perform
challeng
experi
mice
includ
two
strain
civ
one
strain
swine
influenza
viru
siv
consid
almost
civ
isol
report
lethal
mice
dog
challeng
experi
evalu
protect
efficaci
bodi
weight
viral
load
histolog
lesion
bodi
weight
loss
paramet
commonli
use
evalu
influenza
viral
pathogen
mice
studi
show
three
viru
strain
could
remark
reduc
growth
rate
mice
infect
pretreat
mab
help
control
declin
extent
patholog
point
view
lung
heart
brain
mab
treat
group
show
markedli
fewer
lesion
compar
virusinfect
group
mab
igg
group
viru
strain
patholog
score
lung
mab
group
lower
virusinfect
group
mab
igg
group
suggest
mab
could
mitig
damag
caus
influenza
viru
result
suggest
mab
could
offer
protect
effect
three
viru
strain
evalu
effect
antiinfluenza
viru
mab
monitor
viral
load
realtim
pcr
mab
decreas
viral
load
lung
significantli
lower
level
rel
virusinfect
group
mab
igg
group
similar
result
also
found
tissu
viru
brain
organ
three
mice
treat
mab
clear
dpi
except
lung
viru
applic
mab
caus
viru
clearanc
intestin
fece
day
earlier
two
group
moreov
detect
viru
rna
dpi
viru
slower
rate
clearanc
viral
load
observ
viru
could
persist
detect
tissu
mab
group
dpi
viru
intestin
fece
clear
dpi
result
indic
protect
viru
strain
provid
mab
might
caus
earlier
clearanc
viru
tissu
shorten
time
viru
shed
previou
studi
report
mab
could
reduc
period
viru
clearanc
studi
indic
mab
could
provid
good
protect
challeng
homolog
well
heterolog
viru
strain
influenza
viru
find
accord
previou
report
mab
highli
crossreact
among
strain
subtyp
even
within
differ
subtyp
spite
found
mab
rel
less
effect
swinelineag
caninelineag
viru
strain
sequenc
analysi
amino
acid
show
higher
sequenc
ident
caninelineag
swinelineag
differ
amino
acid
respect
data
shown
differ
amino
acid
sequenc
may
affect
antigenantibodi
recognit
may
explain
mab
induc
caninelineag
influenza
viru
strain
strong
enough
react
distantli
relat
strain
within
subtyp
cytokin
import
establish
innat
immun
respons
well
determin
magnitud
inflammatori
respons
influenza
viru
infect
import
featur
mechan
immun
suppress
influenza
viru
cytokin
storm
gain
better
understand
viru
infect
mab
treatment
affect
host
immun
respons
analyz
level
lung
import
find
studi
level
peak
two
day
later
level
group
previou
studi
show
similar
result
lung
pig
infect
human
influenza
viru
peak
dpi
dpi
respect
import
immuneregulatori
function
antivir
activ
primarili
produc
natur
killer
nk
cell
nk
cell
major
player
innat
immun
respons
specul
earli
product
infect
probabl
aris
nk
cell
wherea
function
rel
late
inflammatori
cycl
induc
infect
time
viru
alreadi
contain
respons
center
resolut
inflamm
mice
challeng
maintain
higher
level
dpi
previou
studi
demonstr
deplet
influenza
respiratori
syncyti
virusinfect
anim
significantli
reduc
pulmonari
inflamm
cytokin
product
without
compromis
viral
clearanc
specul
elev
level
dpi
might
correl
unclear
viru
load
lung
present
studi
three
strain
civ
shown
induc
elev
level
cytokin
lung
agreement
previou
report
civ
influenza
viru
infect
elev
proinflammatori
cytokin
respons
propos
main
caus
increas
sever
diseas
studi
lee
et
al
report
level
lung
dog
infect
influenza
viru
increas
quickli
infect
dog
develop
sever
bronchointerstiti
pneumonia
accompani
massiv
infiltr
immun
cell
result
suggest
dysregul
chemokin
civ
infect
might
contribut
viral
pneumonia
character
extens
immun
cell
infiltr
support
hypothesi
observ
elev
level
cytokin
accompani
clinic
manifest
civ
infect
dog
found
level
mab
group
significantli
lower
virusinfect
group
mab
igg
group
histopatholog
find
show
signific
lesion
lung
mice
latter
two
group
mab
group
observ
indic
mab
treatment
may
reduc
virusinduc
cytokin
product
patholog
lesion
caus
viru
infect
effect
like
mediat
inhibit
civ
replic
mab
fritz
et
al
report
activ
influenza
viru
replic
requir
induct
potent
proinflammatori
regulatori
chemotact
factor
studi
previou
report
demonstr
activ
replic
civ
canin
respiratori
system
result
intens
inflammatori
respons
consid
import
host
maintain
balanc
cytokin
level
specul
inhibit
inflammatori
cytokin
respons
might
offer
therapi
civ
infect
howev
salomon
et
al
demonstr
inhibit
cytokin
respons
influenza
viru
infect
suffici
protect
death
propos
therapi
target
viru
would
prefer
conclus
result
suggest
mab
could
contribut
earli
recoveri
influenza
infect
differ
viru
strain
mab
understand
antigen
properti
viru
might
contribut
prevent
control
viru
epidem
dog
